Targeted Dephosphorylation of Tau by Phosphorylation Targeting Chimeras (PhosTACs) as a Therapeutic Modality.

Hu, Zhenyi; Chen, Po-Han; Li, Wenxue; Douglas, Todd; Hines, John; Liu, Yansheng; Crews, Craig M

Hu, Zhenyi; Chen, Po-Han; Li, Wenxue; Douglas, Todd; Hines, John; Liu, Yansheng; Crews, Craig M.

Afiliação

Hu Z; Department of Molecular, Cellular, and Developmental Biology, Yale University, New Haven, Connecticut 06511, United States.
Chen PH; Department of Molecular, Cellular, and Developmental Biology, Yale University, New Haven, Connecticut 06511, United States.
Li W; Department of Biochemistry and Molecular Biology, College of Medicine, National Cheng Kung University, Tainan City 701, Taiwan.
Douglas T; Institute of Basic Medical Sciences, College of Medicine, National Cheng Kung University, Tainan city 701, Taiwan.
Hines J; Yale Cancer Biology Institute, West Haven, Connecticut 06516, United States.
Liu Y; Department of Molecular, Cellular, and Developmental Biology, Yale University, New Haven, Connecticut 06511, United States.
Crews CM; Department of Molecular, Cellular, and Developmental Biology, Yale University, New Haven, Connecticut 06511, United States.

J Am Chem Soc ; 2023 Feb 08.

Article em En | MEDLINE | ID: mdl-36753634

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Idioma: En Revista: J Am Chem Soc Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos